Notably, recent data indicated that CST1 participated in the regulation of cancer progression [14, 15], and researchers found that elevated CST1 promoted cancer progression and predicted a poor prognosis in breast cancer [15]. This evidence concerns the gene CST1 and breast carcinoma.